{
  "id": "mhgap#management_11fa0a6d",
  "content": "is needed to enhance understanding on use in y Decision on the choice and implementation of\nlow-resource settings. psychosocial and/or pharmacological treatment\ny Most studies comparing combined treatment to should be based on individual characteristics of the\npsychosocial interventions were on naltrexone. person it is prescribed for. Service providers should\nFurther research on acamprosate and disulfiram is help the person make decisions about available\nrequired. treatments, based on providing relevant information\n(e.g. possible side-effects, counterindications,\ny Studies comparing combined treatment to\ncosts). Even if it is not possible to provide combined\npharmacological interventions were on acamprosate\ninterventions, individuals should be provided with\nor naltrexone, with no studies on disulfiram. Further\neither psychosocial or pharmacological treatment.\nresearch on disulfiram is required.\ny Even though differences for adverse events were\ny Most studies focused on CBT and combined\nnot identified, medicines for alcohol dependence\nbehavioural interventions with fewer studies on\ntreatment can have side-effects and service\nother psychosocial interventions. Further research is\nproviders should monitor them carefully. The side-\nneeded to understand whether the balance of effects\neffect profile is generally acceptable for most people\ndiffers by type of psychosocial intervention.\nreceiving acamprosate or naltrexone. Education of",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "study",
      "management",
      "psychoeducation"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General â€” Management is needed to enhance understanding on use in y Decision on the choice and implementation of\nlow-resource settings. psychosocial and/or pharmacological treatment\ny Most studies comparing combined treatment to should be based on individual characteristics of the\npsychosocial interventions were on naltrexone. person it is prescribed for. Service providers should\nFurther research on acamprosate and disulfiram is help the person make decisions about available\nrequired. treatments, based on providing relevant information\n(e.g. possible side-effects, counterindications,\ny Studies comparing combined treatment to\ncosts). Even if it is not possible to provide combined\npharmacological interventions were on acamprosate\ninterventions, individuals should be provided with\nor naltrexone, with no studies on disulfiram. Further\neither psychosocial or pharmacological treatment.\nresearch on disulfiram is required.\ny Even though differences for adverse events were\ny Most studies focused on CBT and combined\nnot identified, medicines for alcohol dependence\nbehavioural interventions with fewer studies on\ntreatment can have side-effects and service\nother psychosocial interventions. Further research is\nproviders should monitor them carefully. The side-\nneeded to understand whether the balance of effects\neffect profile is generally acceptable for most people\ndiffers by type of psychosocial intervention.\nreceiving acamprosate or naltrexone. Education of Is needed to enhance understanding on use in y decision on the choice and implementation of\nlow-resource settings. psychosocial and/or pharmacological treatment\ny most studies comparing combined treatment to should be ba..."
}